NCT01286844View on ClinicalTrials.gov

GSK2190915 Pediatric Study

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Asthma
Interventions
DRUG

GSK2190915A 5mg

Oral powder for dispersion in water

DRUG

GSK2190915A 10mg

Oral powder for dispersion in water

DRUG

GSK2190915A 25mg

Oral powder for dispersion in water

DRUG

GSK2190915A 50mg

Oral powder for dispersion in water

DRUG

GSK2190915A 100mg

Oral powder for dispersion in water

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01286844 - GSK2190915 Pediatric Study | Biotech Hunter | Biotech Hunter